Microscopic Polyangiitis (MPA) • 2017 “In 2017 I was diagnosed with MPA that would change my life forever. While my life changed, I learned over time to adapt and adjust to my new reality learning how to live with and thrive with Vasculitis.”...
Amgen Successfully Completes Acquisition of ChemoCentryx
October 20, 2022 GPA Stories, Home Featured, MPA Stories, News & Media
TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat…...